CN106389629A - Traditional Chinese medicine composition for treating eczema pruritus and preparing method thereof - Google Patents
Traditional Chinese medicine composition for treating eczema pruritus and preparing method thereof Download PDFInfo
- Publication number
- CN106389629A CN106389629A CN201610943380.1A CN201610943380A CN106389629A CN 106389629 A CN106389629 A CN 106389629A CN 201610943380 A CN201610943380 A CN 201610943380A CN 106389629 A CN106389629 A CN 106389629A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- active component
- treatment
- eczema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 36
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 14
- 240000005255 Rubus parvifolius Species 0.000 claims abstract description 17
- 235000018803 Rubus parvifolius Nutrition 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 49
- 238000000605 extraction Methods 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000012567 medical material Substances 0.000 claims description 21
- 230000007803 itching Effects 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000012467 final product Substances 0.000 claims description 9
- -1 filtration Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 3
- 244000030166 artemisia Species 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 241000221079 Euphorbia <genus> Species 0.000 abstract description 2
- 241000284147 Clerodendrum fortunatum Species 0.000 abstract 1
- 244000228293 Persicaria perfoliata Species 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 239000002671 adjuvant Substances 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 208000037920 primary disease Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000006188 syrup Substances 0.000 description 8
- 235000020357 syrup Nutrition 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 241001078983 Tetradium ruticarpum Species 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001435059 Artemisia argyi Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 241000871264 Cardiospermum halicacabum Species 0.000 description 1
- 244000067601 Chamaesyce thymifolia Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 108010010803 Gelatin Chemical class 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- KWKVAGQCDSHWFK-VNKDHWASSA-N Methyl sorbate Chemical compound COC(=O)\C=C\C=C\C KWKVAGQCDSHWFK-VNKDHWASSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000173166 Pyrus ussuriensis Species 0.000 description 1
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000008273 gelatin Chemical class 0.000 description 1
- 229920000159 gelatin Chemical class 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating eczema pruritus and a preparing method thereof. The traditional Chinese medicine composition is prepared from persicaria perfoliata, clerodendrum fortunatum, rubus parvifolius, fructus evodiae, thymifoious euphorbia herbs, folium artemisiae argyi and the like. The invention also provides the preparing method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is mainly used for treating eczema pruritus.
Description
Technical field
The present invention relates to the field of Chinese medicines is and in particular to a kind of Chinese medicine composition treating eczema itching over the body and preparation method thereof.
Background technology
Eczema is a kind of allergic skin disease of common easy recurrence, is apt to occur in head, extremity bend side and perineum etc.
Position, is in often general or symmetry distribution.Eczema is multi-cause disease it is considered that closely related with allergy.Part with
Endocrine dysfunction, autonomic nervous dysfunction is relevant；Inherited genetic factorss are also one of primary disease factor.Cause of disease complexity is controlled to primary disease
Treat and bring certain difficulty.
The name of disease of ancient Chinese medicine document no " eczema ", according to its Clinical symptoms, Master Home in " acute eczema ", " noxious dampness " it
Category, but according to its site of pathological change difference, title is different.It is " ecthyma " as be born in shank, be born in the fossa cubitalis or muscular prominence fossa part " four
Curved wind ", is born in scrotum no less than 10 kinds of titles such as " eczema of scrotum ".Earliest record to primary disease, sees《Huang di's Canon of Medicine》.As
《Plain Questions the most pure virginity will be discussed greatly》In touch upon and say in nineteen items of pathogenesis：" all sufferings skin ulcers, come under the heart." Han dynasty Zhang Zhongjing exists《Gold is deficient
Outline》In point out：" acute eczema, Rhizoma Coptidis powder master it." first propose Chinese traditional treatment primary disease side's medicine.Afterwards, ancient Chinese medicine doctor is to this
The understanding of disease is constantly deepened, and such as Sui Dynasty Chao Yuanfang (550-630 A.D.) exists《The General Treatise on the Cause and Symptoms of Diseases》Described in：" all long skin ulcer person ¨ ¨ are taken advantage of by rheumatism, damp and hot
Xiang Bo, therefore head body all gives birth to skin ulcer." explicitly point out wind, wet, hot three evil be main pathogenic, tentatively established the disease of primary disease
Because of pathogenesis basis.Ming Dynasty's Chen Shigong exists《Waike Zhengzong, Orthodox Manual of External Diseases》Supplement improper diet, the damp and hot cause of disease of interior life, and propose to be dissipated with Pulvis concha Mactrae
Outer treating method.Qing Dynasty Wu Qian exists《Yizong Jinjian》Description：" this disease is come into being as scabies, prurituss no when, spread more than, grab Tianjin yellow fluid, wet
Excessive in blocks, formed by the wet wind-engaging of heart-fire spleen." narration of not only clinical symptoms of primary disease having been made in greater detail, and by endogenous cause of ill and
Exopathogenic factor organically combines.Discussed above show, ancient medicine treatment primary disease have accumulated more rich experience.
Modern Chinese medicine treats the clinical report of eczema, sees nineteen fifty-three earliest.From the sixties, clinical article gradually increases
Many, there is case to report, also have the large sample observationses of more than hundred, advocate to combine with external treatment with for oral administration more, also have application
The report of acupuncture and moxibustion therapy primary disease.Enter eight, after the nineties, on the basis of a large amount of practice, to sides such as the etiology and pathogenesis of primary disease
Face has carried out deep people's investigation.As the cause of disease to eczema, always thinking doctor more with wind, wet, hot, malicious based on, by Long-term clinical
Observe, find that blood-deficiency and wind-dry is also that the pathology machine of primary disease one of turns.Differentiation of symptoms and signs for classification of syndrome aspect is just progressively tending to unification.Treatment aspect,
On the basis of Chinese medicine for oral administration is laid equal stress on external treatment, excavate out acupuncture, magnetic therapy, folk prescription proved recipe therapy again, so that curative effect is carried further
High.
Content of the invention
It is an object of the invention to provide a kind of Chinese medicine composition treating eczema itching over the body；
It is a further object of the present invention to provide a kind of preparation method of the Chinese medicine composition treating eczema itching over the body.
The purpose of the present invention is to be realized by following technical scheme：
The Chinese medicine composition for the treatment of eczema itching over the body of the present invention, is to be prepared from by the raw material of Chinese medicine of following weight portion：
Herba Polygoni Perfoliati 15-35 part, triangle bubble 25-45 part, Rubus Parvifolius L. 15-35 part, Fructus Evodiae 5-25 part, Herba Euphorbiae Thymifoliae 15-35 part, Folium Artemisiae Argyi
5-25 part.
Preferably, it is to be prepared from by the raw material of Chinese medicine of following weight portion：
Herba Polygoni Perfoliati 20-30 part, triangle bubble 30-40 part, Rubus Parvifolius L. 20-30 part, Fructus Evodiae 10-20 part, Herba Euphorbiae Thymifoliae 20-30 part, Chinese mugwort
Leaf 10-20 part.
The following is the crude drug source of Chinese medicine preparation of the present invention：
Herba Polygoni Perfoliati, is the herb of polygonaceae plant Herba Polygoni Perfoliati.【Nature and flavor】Bitter, put down.【Indication】Inducing diuresis to remove edema, heat clearing away, promoting blood circulation,
Removing toxic substances.Control edema, jaundice, have loose bowels, malaria, dysentery, pertussis, stranguria with turbid discharge, erysipelas, scrofula, eczema, scabies.
Triangle steeps, and is herb or the fruit of sapindaceous plant Cardiospermum halicacabum.【Nature and flavor】Bitter；Pungent；Cold【Indication】Heat clearing away
Dampness removing；Removing pathogenic heat from blood and toxic substance from the body.Main jaundice；Stranguria；Eczema；Furuncle swelling toxin；Venom；Traumatic injury.
Rubus Parvifolius L., rose family rubus plant Rubus Parvifolius L. Rubus parvifolius., is used as medicine with root or stem, leaf.【Nature and flavor】
Bitter, puckery, cool.【Indication】Clearing away heat and cooling blood, eliminating stagnation, pain relieving, inducing diuresis to remove edema.For cold, fever, laryngopharynx swelling and pain, spitting of blood, tell
Blood, dysentery, enteritis, hepatitis, hepatosplenomegaly, oedema due to nephritis, urinary system infection, calculus, menoxenia, leucorrhea, rheumatic ostalgia, falls
Beat and swell and ache；Eczema, dermatitis are controlled in external.
Fructus Evodiae, is rutaceae Fructus Evodiae Evodia rutaecarpa（Juss.）Benth., Shi Hu Evodia
rutaecarpa（Juss.）Benth. var. officinalis （Dode）Huang or thin hair Fructus Evodiae Evodia
rutaecarpa （Juss.）Benth. var. bodinieri （Dode）Huang is dried almost ripe fruit.【Nature and flavor】Pungent,
Hardship, heat；Slightly poisonous.【Return through】Return liver, spleen, stomach, kidney channel.【Indication】Dispersing cold for relieving pain, stopping nausea and vomiting by lowering the adverse flow of QI, supporing yang antidiarrheal.For
Headache due to JUE YIN disorder, cold hernia stomachache, the disturbance of lower legs due to pathogenic cold and dampness, abdominal pain during menstruation, abdominal distention, vomit acid regurgitation, Diarrhoea, external treatment aphtha；High blood
Pressure.
Herba Euphorbiae Thymifoliae, is Euphorbiaceae euphorbia Euphorbia thymifolia Euphorbia thymifolia L., with all herbal medicine.
【Nature and flavor】Micro- sour, puckery, micro- cool.【Indication】Clearing away heat-damp and promoting diuresis, convergence is antipruritic.Bacillary dysentery, enteritis, diarrhea, bleeding hemorrhoidss；
Eczema, allergic dermatitises, skin pruritus are controlled in external.
Folium Artemisiae Argyi, is the dried leaves of feverfew Chinese mugwort Artemisia argyi Levl. et Vant..【Nature and flavor】It is pungent, bitter,
Temperature；Slightly poisonous.【Return through】Return liver, spleen, kidney channel.【Indication】Dispersing cold for relieving pain, warming the meridian for stopping bleeding.For few abdomen crymodynia, through trembling with fear not
Adjust, uterus cold infertile, spit blood, epistaxis, metrorrhagia is through many, gestation hemorrhage；External treatment skin pruritus.Vinegar Chinese mugwort charcoal warming the meridian for stopping bleeding.For deficiency and coldness
Property bleeding.
Another aspect of the present invention there is provided the preparation method of the active component of Chinese medicine composition of the present invention, and the method is
Ethanol extraction using water extraction or 40-80% concentration expressed in percentage by volume is prepared from.Concrete preparation method is as follows：
Scheme one：Take whole medical materials, extracting in water 2-3 time after mixing, each amount of water is equivalent to 6-12 times of medical material gross weight,
Extraction time is 1-3 hour every time, united extraction liquid, filtration, and it is 1.15-1.20 that filtrate is concentrated into relative density when 70-80 DEG C
Clear paste, obtain final product active component.
Scheme two：Take whole medical materials, after mixing, use 40-80% alcohol reflux 2-3 time, each ethanol consumption is medical material total amount
4-10 times, extraction time is 1-4 hour, and united extraction liquid filters, filtrate is concentrated into relative density when 70-80 DEG C and is
The clear paste of 1.15-1.20, obtains final product active component.
Scheme three：Take whole medical materials, extracting in water 2-3 time after mixing, each amount of water is equivalent to the 6- of medical material gross weight
12 times, each extraction time is 1-3 hour, united extraction liquid, filtration, and filtrate is concentrated into relative density when 70-80 DEG C and is
The clear paste of 1.15-1.20, adds ethanol, makes alcohol content be 40-70%, stands 12-24 hour, filtration, filtrate is concentrated into 70-80
DEG C when relative density be 1.10-1.25 extractum, obtain final product active component.
The Chinese medicine composition for the treatment of eczema itching over the body of the present invention, can also be joined with pharmaceutically acceptable carrier
Close, make various oral formulations, such as pill, tablet, capsule, oral liquid, syrup, mixture etc..
The pharmaceutically acceptable carrier of the present invention is including but not limited to following：
Oral formulations：
Diluent：Starch, Icing Sugar, Lactose, dextrin, Microcrystalline Cellulose, inorganic salt, sugar alcohols etc..
Wetting agent and binding agent：Purified water, ethanol, gelatin, Polyethylene Glycol, cellulose derivative etc..
Disintegrating agent：Starch, carboxymethyl starch sodium, cellulose derivative, Crospovidone etc..
Lubricant：Magnesium stearate, micropowder silica gel, Pulvis Talci, Polyethylene Glycol etc..
Cosolvent：Water, ethanol, glycerol, propylene glycol, liquid Paraffin, vegetable oil etc..
Correctivess：Sucrose, monosaccharide, aromatic etc..
Preservative：Benzoic acid, sorbic acid, methyl ester, ethyl ester, propyl ester etc..
Method 1：Tablet
Take scheme one one of to scheme three gained active component, add tablet to commonly use adjuvant, routinely production method is prepared into this
Invention tablet.
Above-mentioned tablet is commonly used adjuvant and is included one of diluent, wetting agent, binding agent, disintegrating agent, lubricant or whole.
Method 2：Capsule
Take scheme one one of to scheme three gained active component, add capsule to commonly use adjuvant, routinely production method is prepared into
Capsule of the present invention.
Above-mentioned capsule is commonly used adjuvant and is included one of diluent, wetting agent, binding agent, disintegrating agent, lubricant or whole.
Method 3：Syrup
Take scheme one one of to scheme three gained active component, add syrup to commonly use adjuvant, routinely production method is prepared into
Syrup of the present invention.
Above-mentioned syrup is commonly used adjuvant and is included one of correctivess, preservative, cosolvent or whole.
Method 4：Mixture
Take scheme one one of to scheme three gained active component, add mixture to commonly use adjuvant, routinely production method is prepared into this
Invention mixture.
Above-mentioned mixture is commonly used adjuvant and is included one of correctivess, preservative or whole.
Method 5：Oral liquid
Take scheme one one of to scheme three gained active component, dissolving after-purification, concentration, add oral liquid to commonly use adjuvant, by normal
Rule production method is prepared into oral liquid of the present invention.
The applicant reads document at all times extensive, with Traditional Chinese medical theory, in conjunction with modern diagnosis and treatment experience, finds one kind
The Chinese medicine composition for the treatment of eczema itching over the body disease.Square intermediate cam bubble clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body；Herba Polygoni Perfoliati heat-clearing and toxic substances removing, dampness removing,
For monarch drug in side；Rubus Parvifolius L. clearing away heat and cooling blood, Herba Euphorbiae Thymifoliae clearing away heat-damp and promoting diuresis are antipruritic and are minister；Fructus Evodiae, Folium Artemisiae Argyi cold expelling dampness removing, and be
Assistant.Take a broad view of full side, there is the effect of heat-clearing and toxic substances removing, blood-cooling itch-relieving, cold expelling dampness removing.Treatment for eczema itching over the body.
A kind of Chinese medicine composition treating eczema itching over the body that the present invention provides has advantages below：
1st, the composite preparation that the present invention provides safely and effectively, has the effect of heat-clearing and toxic substances removing, blood-cooling itch-relieving, cold expelling dampness removing.With
Treatment in eczema itching over the body.
2nd, the Chinese medicinal composition preparation that the present invention provides, scientific formulation is reasonable, process is simple, in good taste, low cost.
Specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for illustrating
The present invention rather than limitation of the present invention.Broadly fall into the present invention according to the simple modifications that the essence of the present invention is carried out to the present invention
Claimed scope.Unless otherwise stated, the percent of the amount of alcohol in the present invention is percentage by volume, and v/v represents solution
Volume ratio.
Embodiment 1 granule
Weigh Herba Polygoni Perfoliati 15g, triangle bubble 25g, Rubus Parvifolius L. 15g, Fructus Evodiae 5g, Herba Euphorbiae Thymifoliae 15g, Folium Artemisiae Argyi 5g.Extracting in water 3 times,
Three amount of water are respectively 12 times, 8 times, 6 times of medical material gross weight, and three extraction times are respectively 3 hours, 2 hours, 1 hour,
United extraction liquid, filtration, when filtrate is concentrated into 70 DEG C, relative density is 1.25 clear paste, adds starch, dextrin, pelletize, be dried,
Granulate obtains final product.
Embodiment 2 tablet
Weigh Herba Polygoni Perfoliati 35g, triangle bubble 45g, Rubus Parvifolius L. 35g, Fructus Evodiae 25g, Herba Euphorbiae Thymifoliae 35g, Folium Artemisiae Argyi 25g.Use alcohol reflux
Extract 2 times, each concentration of alcohol is respectively 80%, 60%, each ethanol consumption is respectively 10 times, 8 times of medical material total amount, during extraction
Between be respectively 4 hours, 3 hours, united extraction liquid, filter, when filtrate is concentrated into 80 DEG C, relative density is 1.10 extractum, add
Supplementary product starch, ethanol, Pulvis Talci, prepared tablet.
Embodiment 3 tablet
Weigh Herba Polygoni Perfoliati 20g, triangle bubble 30g, Rubus Parvifolius L. 20g, Fructus Evodiae 10g, Herba Euphorbiae Thymifoliae 20g, Folium Artemisiae Argyi 10g.Extracting in water 3
Secondary, three times amount of water is respectively equivalent to 12 times of medical material gross weight, 8 times, 6 times, 3 hours respectively each extraction time, 2 hours, 1
Hour, united extraction liquid, filtration, when filtrate is concentrated into 70 DEG C, relative density is 1.20 clear paste, adds ethanol, makes the alcohol content be
40%, stand 24 hours, filtration, filtrate is concentrated into the extractum that relative density when filtrate is concentrated into 70 DEG C is 1.10, adds adjuvant to form sediment
Powder, ethanol, Pulvis Talci, prepared tablet.
Embodiment 4 capsule
Weigh Herba Polygoni Perfoliati 30g, triangle bubble 40g, Rubus Parvifolius L. 30g, Fructus Evodiae 20g, Herba Euphorbiae Thymifoliae 30g, Folium Artemisiae Argyi 20g.Returned with 40% ethanol
Stream extracts 3 times, and each ethanol consumption is respectively 10 times, 8 times, 4 times of medical material total amount, 3 hours respectively extraction time, 2 hours, 1
Hour, united extraction liquid, filter, filtrate concentrate 60 DEG C when relative density be 1.25 extractum, in extractum add supplementary product starch,
Ethanol, dextrin, magnesium stearate, make capsule according to a conventional method.
Embodiment 5 granule
Weigh Herba Polygoni Perfoliati 25g, triangle bubble 35g, Rubus Parvifolius L. 25g, Fructus Evodiae 15g, Herba Euphorbiae Thymifoliae 25g, Folium Artemisiae Argyi 15g.Extracting in water 2
Secondary, each amount of water is respectively equivalent to 12 times of medical material gross weight, 10 times, and each extraction time is respectively 3 hours, 2 hours, closes
And extracting solution, filtration, filtrate is concentrated into the clear paste that relative density at 80 DEG C is 1.05, adds ethanol, makes alcohol content be 70%, quiet
Put 12 hours, filtration, when filtrate is concentrated into 70 DEG C, relative density is 1.25 extractum, add starch, dextrin, pelletize, dry, whole
Grain obtains final product.
Embodiment 6 syrup
Weigh Herba Polygoni Perfoliati 18g, triangle bubble 28g, Rubus Parvifolius L. 18g, Fructus Evodiae 8g, Herba Euphorbiae Thymifoliae 18g, Folium Artemisiae Argyi 8g.Extracting in water 2 times,
Amount of water is respectively 10 times, 8 times of medical material gross weight twice, twice extraction time respectively 2 hours, 1 hour, united extraction
Liquid, filtration, when filtrate is concentrated into 80 DEG C, relative density is 1.10 extractum.Syrup adjuvant sucrose, Pyrusussuriensiss are added in extractum
Acid, water stir, prepared syrup.
Embodiment 7 oral liquid
Weigh Herba Polygoni Perfoliati 23g, triangle bubble 32g, Rubus Parvifolius L. 23g, Fructus Evodiae 12g, Herba Euphorbiae Thymifoliae 23g, Folium Artemisiae Argyi 12g.Extracting in water 2
Secondary, amount of water is respectively 10 times, 8 times of medical material gross weight twice, twice extraction time respectively 2 hours, 1 hour, and merging carries
Take liquid, filtration, when filtrate is concentrated into 80 DEG C, relative density is 1.10 extractum, in extractum add adjuvant Mannitol, sorbic acid,
Water stirs, subpackage, prepared oral liquid.
Embodiment 8 mixture
Weigh Herba Polygoni Perfoliati 28g, triangle bubble 38g, Rubus Parvifolius L. 28g, Fructus Evodiae 18g, Herba Euphorbiae Thymifoliae 28g, Folium Artemisiae Argyi 18g.Extracting in water 3
Secondary, three times amount of water is respectively equivalent to 12 times of medical material gross weight, 8 times, 6 times, 3 hours respectively each extraction time, 2 hours, 1
Hour, united extraction liquid, filtration, filtrate concentration ad pond om is 3 times of medical material gross weight, fill, addition mixture adjuvant sucrose,
Ethyl ester, water, sorbic acid stir, prepared mixture.
Embodiment 9 powder
Weigh Herba Polygoni Perfoliati 32g, triangle bubble 42g, Rubus Parvifolius L. 32g, Fructus Evodiae 23g, Herba Euphorbiae Thymifoliae 32g, Folium Artemisiae Argyi 23g.Pulverize, sieve,
Obtain final product.
Model case
1st, multitude XX, man, 38 years old.Suffer from eczema 4 years, meet winter to disappear, often send out to spring.Can not go out for every to work, misery is very.
Endo-medicine or medication washout affected part effect be not all good.Examine meeting portion and two handss forearms, huckle are abound with cerise erythema, mound
Rash, but no blister, substantially, prurituss are very acute for edema, and burning sensation substantially, has thirsty, dry stool, pale tongue, white and thin fur, moderate pulse concurrently.Card
Belong to dysfunction of the spleen in transportation, retention of damp-heat in the interior, diseases caused by exogenous pathogenic factor rheumatic fever.Give the embodiment of the present invention 4 to treat, take medicine 3 days, rash disappear itch flat.Take 7 space-baseds
This recovery from illness.Subsequently take 5 days, pertinacious disease is cured.
2nd, magnificent X, female, 47 years old.No obvious inducement appearance face, napex, back erythra before 5 days, prominent skin, pale red,
Sparse distribution, slightly itches, and that grabs goes out pus point, and that grabs goes out a little muddy water thing like as pus, does not press from both sides blood.Give the embodiment of the present invention 8 to control
Treat, have within 1 day pox of itching to see and subtract, after 3 days pox section itch several only；Continue 3 days, pox of itching section disappears, and so far there are no remakes.
Although, above used general explanation, specific embodiment and test, the present invention made retouch in detail
State, but on the basis of the present invention, it can be made some modifications or improvements, this is apparent to those skilled in the art
's.Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, belong to claimed
Scope.
Claims (7)
1. a kind of Chinese medicine composition treating eczema itching over the body is it is characterised in that it is by the raw material of Chinese medicine preparation of following weight portion
Become：
Herba Polygoni Perfoliati 15-35 part, triangle bubble 25-45 part, Rubus Parvifolius L. 15-35 part, Fructus Evodiae 5-25 part, Herba Euphorbiae Thymifoliae 15-35 part, Folium Artemisiae Argyi
5-25 part.
2. the Chinese medicine composition for the treatment of eczema itching over the body as claimed in claim 1 is it is characterised in that it is by the following weight of inclusion
The raw material of Chinese medicine of part is prepared from：
Herba Polygoni Perfoliati 20-30 part, triangle bubble 30-40 part, Rubus Parvifolius L. 20-30 part, Fructus Evodiae 10-20 part, Herba Euphorbiae Thymifoliae 20-30 part, Chinese mugwort
Leaf 10-20 part.
3. the Chinese medicine composition for the treatment of eczema itching over the body as claimed in claim 1 or 2 is it is characterised in that its active component is to adopt
It is prepared from the ethanol extraction of water extraction or 40-80% concentration expressed in percentage by volume.
4. the Chinese medicine composition for the treatment of eczema itching over the body as claimed in claim 3 is it is characterised in that its active component is to pass through
Following methods are prepared from：Take whole medical materials, extracting in water 2-3 time after mixing, each amount of water is equivalent to medical material gross weight
6-12 times, each extraction time is 1-3 hour, united extraction liquid, filtration, and filtrate is concentrated into relative density when 70-80 DEG C and is
The clear paste of 1.15-1.20, obtains final product active component.
5. the Chinese medicine composition for the treatment of eczema itching over the body as claimed in claim 3 is it is characterised in that its active component is to pass through
Following methods are prepared from：Take whole medical materials, after mixing, use 40-80% alcohol reflux 2-3 time, each ethanol consumption is
4-10 times of medical material total amount, extraction time is 1-4 hour, and united extraction liquid filters, filtrate is concentrated into relatively close when 70-80 DEG C
Spend the clear paste for 1.15-1.20, obtain final product active component.
6. the Chinese medicine composition for the treatment of eczema itching over the body as claimed in claim 3 is it is characterised in that its active component is to pass through
Following methods are prepared from：Take whole medical materials, extracting in water 2-3 time after mixing, each amount of water is equivalent to medical material gross weight
6-12 times, each extraction time is 1-3 hour, united extraction liquid, filtration, and filtrate is concentrated into relative density when 70-80 DEG C and is
The clear paste of 1.15-1.20, adds ethanol, makes alcohol content be 40-70%, stands 12-24 hour, filtration, filtrate is concentrated into 70-80
DEG C when relative density be 1.10-1.25 extractum, obtain final product active component.
7. a kind of preparation treating eczema itching over the body, the Chinese medicine composition for the treatment of eczema itching over the body described in claim 1-6 and doctor
Pharmaceutically acceptable carrier prepares and forms.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610943380.1A CN106389629A (en) | 2016-11-02 | 2016-11-02 | Traditional Chinese medicine composition for treating eczema pruritus and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610943380.1A CN106389629A (en) | 2016-11-02 | 2016-11-02 | Traditional Chinese medicine composition for treating eczema pruritus and preparing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106389629A true CN106389629A (en) | 2017-02-15 |
Family
ID=58013672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610943380.1A Withdrawn CN106389629A (en) | 2016-11-02 | 2016-11-02 | Traditional Chinese medicine composition for treating eczema pruritus and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106389629A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107715077A (en) * | 2017-12-08 | 2018-02-23 | 叶盛清 | A kind of Chinese medicine composition for treating palpitaition and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383378A (en) * | 2014-10-30 | 2015-03-04 | 梁春林 | Traditional Chinese medicine composition for treating eczema pruritus and preparation method of traditional Chinese medicine composition |
-
2016
- 2016-11-02 CN CN201610943380.1A patent/CN106389629A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383378A (en) * | 2014-10-30 | 2015-03-04 | 梁春林 | Traditional Chinese medicine composition for treating eczema pruritus and preparation method of traditional Chinese medicine composition |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107715077A (en) * | 2017-12-08 | 2018-02-23 | 叶盛清 | A kind of Chinese medicine composition for treating palpitaition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102205026B (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
| CN101455738B (en) | Traditional Chinese medicine composition for treating eczema and preparation method thereof | |
| CN103520607B (en) | Traditional Chinese medicine preparation used for treating gastritis | |
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN104324125B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN102988733A (en) | Traditional Chinese medicine composition for treating postpartum hypogalactia and preparation method thereof | |
| CN103055066A (en) | Traditional Chinese medicine for improving sleep and preparation method thereof | |
| CN104800817A (en) | Medicinal composition for treating dog rhinitis and preparation method thereof | |
| CN106389629A (en) | Traditional Chinese medicine composition for treating eczema pruritus and preparing method thereof | |
| CN105797063A (en) | Orally taken medicine for treating gallstones and preparation method thereof | |
| CN105327285A (en) | Medicine used for treating antral gastritis | |
| CN104940672A (en) | Traditional Chinese medicine for treatment of gallstone and preparation method | |
| CN104324185A (en) | Traditional Chinese medicine composition for treating leukorrhagia and preparation method thereof | |
| CN104127737A (en) | Pharmaceutical composition for preventing and treating postoperative complications of haemorrhoids and preparation method of pharmaceutical composition | |
| CN102526644A (en) | Chinese medicine preparation for treating cholecystolithiasis | |
| CN106421164A (en) | Traditional Chinese medicine composition for treating dysentery and preparation method thereof | |
| CN104857255A (en) | Traditional Chinese medicine preparation for treating suppurative otitis media and preparation method | |
| CN105998781A (en) | Pharmaceutical composition for treating acute gastroenteritis | |
| CN105031063A (en) | Beverage for treating chronic pelvic inflammatory disease | |
| CN105396007A (en) | Gynecological topical lotion for preventing and treating colpitis mycotica | |
| CN105688075A (en) | Novel oral preparation for treating stomachache and preparation method thereof | |
| CN104887933A (en) | Medicine for curing accumulated damp-heat chronic pelvic inflammation | |
| CN104524460A (en) | Pharmaceutical composition for preventing and treating acute nephritis and application thereof | |
| CN104524149A (en) | Pharmaceutical composition for preventing and treating acute nephritis and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170215 |